The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway

Abstract Erythroleukemia is a rare hematological malignancy in clinical practice, and currently, there are no effective treatment options other than stem cell transplantation. The study found that the fluoroquinoline compound FKL-137 can significantly inhibit the proliferation of erythroleukemia cel...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sha Cheng, Weijia Zhao, Jia Yu, Xueling Meng, Bixue Xu, Ningning Zan, Baofei Sun, Heng Luo
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2026-03-01
Цуврал:	Scientific Reports
Нөхцлүүд:	Fluoroquinoline Erythroleukemia GLUT1 PI3K/AKT Glucose metabolism Glycolysis
Онлайн хандалт:	https://doi.org/10.1038/s41598-026-45597-9
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!